Read more at The Wall Street Journal.
Activist Starboard Value Takes $1 Billion Stake in Pfizer
Date: |
-
Business - Financial Times
Former Pfizer CEO pitches board on Starboard’s shake-up plan
Ian Read has called his successors about the activist’s ideas for turning around the vaccine maker11 hours ago -
Business - The Wall Street Journal
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.2 hours ago -
Business - Financial Times
Norway’s Equinor takes 10% stake in renewables group Ørsted
Company becomes second-largest shareholder in world’s biggest offshore wind farm developer behind Danish government16 hours ago -
Business - The Wall Street Journal
Apollo Global to Take Barnes Group Private in $3.6 Billion Deal
Barnes Group has agreed to be acquired and taken private by Apollo Global Management in an all-cash deal that values the company at $3.6 billion.19 hours ago -
Business - The Wall Street Journal
Cannae, KDSA Buy Majority Stake in The Watkins Company
Cannae, a Las Vegas-based company led by billionaire Bill Foley, includes holdings in the English Premier League team AFC Bournemouth, restaurant chains Ninety Nine Restaurant & Pub and ...8 hours ago -
World - The New York Times
A Young Activist Arrested in Zimbabwe Holds Onto Her ‘Why’
Namatai Kwekweza said she remained committed to her advocacy for change in Africa, despite a harrowing experience in Zimbabwe.4 hours ago -
World - The New York Times
Athens Democracy Forum: Young Activists on What Drives Them
Six young people from around the world who attended the Athens Democracy Forum spoke about what drives them and the challenges they face.4 hours ago -
Business - The Wall Street Journal
Equinor Buys 9.8% Stake in Orsted as Part of Renewables Push
Equinor plans to allocate more than 50% of its investments in renewable and low-carbon projects by 2050, from around 20% in 2023.17 hours ago
More from The Wall Street Journal
-
Business - The Wall Street Journal
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.2 hours ago -
Business - The Wall Street Journal
Decision Time for GM in China: Stay, Scale Back or Go
The country’s sharp shift to EVs and stronger local competition have deflated a key profit engine for the U.S. automaker.2 hours ago -
Business - The Wall Street Journal
Cannae, KDSA Buy Majority Stake in The Watkins Company
Cannae, a Las Vegas-based company led by billionaire Bill Foley, includes holdings in the English Premier League team AFC Bournemouth, restaurant chains Ninety Nine Restaurant & Pub and ...8 hours ago -
Business - The Wall Street Journal
Basic Materials Roundup: Market Talk
Read about Sherwin-Williams, Arcadium Lithium and more in the latest Market Talks covering Basic Materials.9 hours ago -
Business - The Wall Street Journal
Health Care Roundup: Market Talk
Find insight on Pfizer, Riverstone, Top Glove Corp. and more in the latest Market Talks covering the Health Care sector.9 hours ago